You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Resectable

Showing 26 - 50 of 2,698
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Locally Advanced Unresectable Gastric Adenocarcinoma Trial in Tianjin (Oxaliplatin, Capecitabine, Cadonilimab)

Not yet recruiting
  • Locally Advanced Unresectable Gastric Adenocarcinoma
  • Tianjin, Tianjin, China
    Xuewei Ding
Aug 2, 2023

Stage II-IIIB(N2) NSCLC Trial in Shanghai (TQB2450, Carboplatin, Pemetrexed)

Not yet recruiting
  • Stage II-IIIB(N2) Non-small Cell Lung Cancer
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
Oct 26, 2023

Cancer of Stomach Trial (Surgery procedure)

Not yet recruiting
  • Cancer of Stomach
  • Surgery procedure
  • (no location specified)
Feb 16, 2023

NSCLC Trial (Dupilumab, Cemiplimab)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Dupilumab
  • Cemiplimab
  • (no location specified)
Oct 12, 2023

Pancreas Cancer, Non-Resectable Pancreas Carcinoma Trial in Aalborg (Gemcitabine, Nab paclitaxel)

Not yet recruiting
  • Pancreas Cancer
  • Non-Resectable Pancreas Carcinoma
  • Aalborg, Denmark
    Department of Oncology, Aalborg University Hospital
May 1, 2023

Stomach Tumor Trial (aerobic exercise; resistance exercise; nutritional support; psychological support)

Not yet recruiting
  • Stomach Neoplasm
  • aerobic exercise; resistance exercise; nutritional support; psychological support
  • (no location specified)
Feb 2, 2023

Locally Advanced Hypopharyngeal Carcinoma Trial in Shanghai (drug, procedure, radiation)

Not yet recruiting
  • Locally Advanced Hypopharyngeal Carcinoma
  • three cycles (toripalimab + cetuximab + platinum)
  • +2 more
  • Shanghai, Shanghai, China
    Eye & ENT Hospital of Fudan University
Nov 22, 2023

Perihilar Cholangiocarcinoma Trial in Amsterdam (Intrahepatic biliary stent with retrieval string)

Recruiting
  • Perihilar Cholangiocarcinoma
  • Intrahepatic biliary stent with retrieval string
  • Amsterdam, Netherlands
    Amsterdam UMC
May 23, 2023

Resectable Pancreatic Cancer Trial in Tianjin (AG Followed by FOLFIRINOX)

Recruiting
  • Resectable Pancreatic Cancer
  • AG Followed by FOLFIRINOX
  • Tianjin, Tianjin, China
    Rui Liu
Jan 8, 2023

Lung Cancer Trial (Cadonilimab)

Not yet recruiting
  • Lung Cancer
  • (no location specified)
Mar 23, 2023

HER2-positive Locally Advanced Resectable Gastric Cancer Trial (KN026, KN046, XELOX)

Not yet recruiting
  • HER2-positive Locally Advanced Resectable Gastric Cancer
  • (no location specified)
Sep 3, 2023

Colorectal Cancer, Liver Metastases Trial in Shanghai (mFOLFOX6 + Cetuximab, mFOLFOX 6)

Not yet recruiting
  • Colorectal Cancer
  • Liver Metastases
  • mFOLFOX6 + Cetuximab
  • mFOLFOX 6
  • Shanghai, China
    Zhongshan hosptial, Fudan University
Jul 14, 2023

Pancreatic Cancer Trial in Baltimore (Gemcitabine, Cisplatin, Pembrolizumab)

Not yet recruiting
  • Pancreatic Cancer
  • Baltimore, Maryland
    SKCCC Johns Hopkins
Aug 16, 2023

Immunotherapy;Envafolimab; Esophageal Cancer Trial (Envafolimab, Abraxane, Cisplatin)

Not yet recruiting
  • Immunotherapy;Envafolimab; Esophageal Cancer
  • (no location specified)
Apr 24, 2023

Melanoma Stage III Trial in Shanghai (Toripalimab combined with Temozolomide)

Not yet recruiting
  • Melanoma Stage III
  • Toripalimab combined with Temozolomide
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Apr 23, 2023

Resectable Hepatocellular Carcinoma, Hepatocellular Carcinoma, Hepatocellular Cancer Trial in Boston (Durvalumab, Tremelimumab,

Not yet recruiting
  • Resectable Hepatocellular Carcinoma
  • +2 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 18, 2023

Esophageal Carcinoma, Neoadjuvant Therapy Trial (Toripalimab, Anlotinib HCl, Albumin paclitaxel)

Not yet recruiting
  • Esophageal Carcinoma
  • Neoadjuvant Therapy
  • (no location specified)
Aug 16, 2023

Pancreatic Cancer Resectable Trial (Acetylsalicylic acid, Placebo)

Not yet recruiting
  • Pancreatic Cancer Resectable
  • Acetylsalicylic acid
  • Placebo
  • (no location specified)
Dec 5, 2022

Borderline Resectable Pancreatic Cancer Trial in Verona (Intraoperative radiotherapy)

Suspended
  • Borderline Resectable Pancreatic Cancer
  • Intraoperative radiotherapy
  • Verona, Italy
    General and Pancreatic Surgery Unit, Pancreas Institute, Univers
Nov 1, 2022

Predicts Lymph Node Metastasis in Resectable Adenocarcinoma of

Completed
  • Pancreas Cancer
    • (no location specified)
    Jul 15, 2023

    Resectable Stage II-IIIB Driver Gene-negative Non-small Cell

    Not yet recruiting
    • NSCLC
      • Changsha, Hunan, China
        Hunan Cancer Hospital
      Aug 6, 2023

      NSCLC With Mutation in Epidermal Growth Factor Receptor Trial (Osimertinib, Aspirin)

      Not yet recruiting
      • Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor
      • (no location specified)
      Aug 27, 2023

      Lung Adenocarcinoma Stage III, Lung Adenocarcinoma Stage IV, EGFR Gene Mutation Trial in Shanghai (Furmonertinib, Bevacizumab)

      Recruiting
      • Lung Adenocarcinoma Stage III
      • +2 more
      • Shanghai, Shanghai, China
        Shanghai Pulmonary Hospital
      Aug 13, 2022

      Osteosarcoma Trial in Shanghai (metastasectomy and pre-operative immunotherapy (gemcitabine and penpulimab ) and stereotactic

      Recruiting
      • Osteosarcoma
      • metastasectomy and pre-operative immunotherapy (gemcitabine and penpulimab ) and stereotactic body radiotherapy
      • Shanghai, Shanghai, China
        Ruijin Hospital, Shanghai Jiao Tong University, School of Medici
      Nov 1, 2023

      Cholangiocarcinoma Trial in Houston (Pembrolizumab, Gemcitabine, Cisplatin)

      Not yet recruiting
      • Cholangiocarcinoma
      • Houston, Texas
        M D Anderson Cancer Center
      Jul 21, 2023